JDR JDR Most Read Articles
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fréchette, J.-P.
Right arrow Articles by Gagnon, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fréchette, J.-P.
Right arrow Articles by Gagnon, G.

Platelet-rich Plasmas: Growth Factor Content and Roles in Wound Healing

J.-P. Fréchette, I. Martineau, and G. Gagnon*

Faculté de médecine dentaire, Université Laval, Québec, Province Québec, Canada G1K 7P4;



View larger version (33K):

[in a new window]
 
Figure 1. GF and cytokine concentrations in PRP supernatants over a six-day incubation period at 37°C. (A) Mean EGF concentration (pg/mL). (B) Mean IGF-1 concentration (pg/mL). (C) Mean Ang-2 concentration (pg/mL). (D) Mean IL-1ß concentration (pg/mL). Final thrombin and CaCl2•2H2O concentrations added in PRPs were: (for condition A) 142.8 U/mL and 14.3 mg/mL; (for condition B) 28.56 U/mL and 2.86 mg/mL; and (for condition C) 5.71 U/mL and 0.57 mg/mL, respectively. Bars on histogram indicate mean ± SEM (standard error of mean). Numbers above the column represent the ratio (fold) obtained when the GF/cytokine concentration at each time was divided by the GF/cytokine concentration at t = 0 hrs. All assays were performed in triplicate for each donor, and each column represents the mean of five donors.

 


View larger version (26K):

[in a new window]
 
Figure 2. Cellular proliferation after treatment with PRP supernatants from five donors. (A) HUVEC proliferation rates. (B) hFOB 1.19 osteoblast proliferation rates. PRP supernatants (10% v/v) were added to minimal medium. Conditions A, B, and C are described in Fig. 1Go. All assays were performed in triplicate, and each column represents the mean ± SEM of five donors.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2005 Institutional Access Guidelines